Should We Screen for Vitamin D Deficiency?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center

Area of Science:

• Endocrinology
• Preventive Medicine
• Clinical Practice Guidelines

Background:

• The U.S. Preventive Services Task Force (USPSTF) updated guidelines on vitamin D deficiency screening.
• Evidence synthesis included randomized trials and case-control studies.

Observation:

• Vitamin D supplementation showed decreased mortality in initial analyses, but this benefit disappeared when excluding trials of institutionalized individuals.
• Vitamin D treatment was linked to a potential reduction in falls but not fractures.
• No studies directly compared vitamin D screening versus no screening for clinical outcomes.

Findings:

• The USPSTF concluded that evidence is insufficient to recommend for or against screening for vitamin D deficiency in asymptomatic adults.
• The debate highlights the complexities of interpreting existing data for clinical decision-making.

Implications:

• Primary care physicians face challenges in deciding whether to screen for vitamin D deficiency.
• Further research is needed to clarify the clinical utility of vitamin D screening and treatment in specific populations.